ArticleJournal of managed care & specialty pharmacy2018

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective.

Lindsay Claxton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.